Alkermes to Take Part in Cantor Virtual Global Healthcare Conference

Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) announced participation in the Cantor Virtual Global Healthcare Conference on Sept. 16, 2020, at 10:40 a.m. ET. CEO Richard Pops will engage in a fireside chat, which can be accessed via the company's website and archived for 14 days. Alkermes is a global biopharmaceutical company focused on innovative medicines for neuroscience and oncology, with commercial products targeting addiction and schizophrenia, and a development pipeline for various mental health and cancer therapies.

Positive

• Participation in a notable healthcare conference, potentially enhancing investor visibility.

Negative

• None.

DUBLIN, Sept. 9, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that that its Chief Executive Officer, Richard Pops, will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Wednesday, Sept. 16, 2020 at 10:40 a.m. ET (3:40 p.m. BST). The webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-take-part-in-cantor-virtual-global-healthcare-conference-301126833.html

SOURCE Alkermes plc

FAQ

When is Alkermes participating in the Cantor Virtual Global Healthcare Conference?

Alkermes will participate in the Cantor Virtual Global Healthcare Conference on Sept. 16, 2020, at 10:40 a.m. ET.

Who from Alkermes will speak at the conference?

CEO Richard Pops will participate in the fireside chat at the conference.

Where can I access the webcast of Alkermes' conference participation?

The webcast can be accessed under the Investors tab on Alkermes' website and will be archived for 14 days.

What are the main focuses of Alkermes plc?

Alkermes focuses on developing innovative medicines in neuroscience and oncology, particularly for addiction and schizophrenia.